CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Huaren Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Huaren Pharmaceutical Co Ltd
No.187 Zhuzhou Road
Hi-tech Industrial Park
Phone: +86 53258070788p:+86 53258070788 QINGDAO, SDG  266101  China Ticker: 300110300110
Business Summary
Huaren Pharmaceutical Co Ltd is a China-based company principally engaged in pharmaceutical business, medical devices and medical packaging business, big health business, and pharmaceutical commercial circulation business. The pharmaceutical business is mainly engaged in the research and development, production and sales of large-volume preparations, peritoneal dialysis fluid products, and respiratory and anesthesia products. The medical devices and medical packaging business is mainly engaged in the research and development, production and sales of puncture devices, incision retractors, ziplock bags, wrapping films, and other products. The big health business is mainly engaged in big health product lines such as beverages, cosmetics, and health drinks. The pharmaceutical commercial circulation business is mainly engaged in the wholesale business of drugs, medical devices, pharmaceutical raw materials and others. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
5122 Drugs, drug proprietaries, and druggists' sundries
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board XiaodongYang 55 9/12/2023 8/1/2019
Executive President LiangHong 52 9/12/2023 9/12/2023
President JianLi 40 9/12/2023 9/12/2023
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,681 (As of 12/31/2023)
Outstanding Shares: 1,182,212,982 (As of 9/30/2024)
Shareholders: 48,384
Stock Exchange: SHE
Fax Number: +86 53258070286


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 8, 2025